{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,27]],"date-time":"2026-08-27T00:54:21Z","timestamp":1787792061425,"version":"build-2784847793"},"reference-count":35,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2025,11,25]],"date-time":"2025-11-25T00:00:00Z","timestamp":1764028800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,11,25]],"date-time":"2025-11-25T00:00:00Z","timestamp":1764028800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["8227010768"],"award-info":[{"award-number":["8227010768"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004826","name":"Natural Science Foundation of Beijing Municipality","doi-asserted-by":"publisher","award":["7252147"],"award-info":[{"award-number":["7252147"]}],"id":[{"id":"10.13039\/501100004826","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Bone Marrow Transplant"],"published-print":{"date-parts":[[2026,2]]},"DOI":"10.1038\/s41409-025-02746-4","type":"journal-article","created":{"date-parts":[[2025,11,25]],"date-time":"2025-11-25T13:28:31Z","timestamp":1764077311000},"page":"159-165","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Incidence and risk factors for graft failure after allogeneic hematopoietic stem cell transplantation in patients with myelofibrosis"],"prefix":"10.1038","volume":"61","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1856-2231","authenticated-orcid":false,"given":"Yuqian","family":"Sun","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jia","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0237-6063","authenticated-orcid":false,"given":"Erlie","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Borui","family":"Tang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinchuan","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3857-5574","authenticated-orcid":false,"given":"Yanmin","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6146-5894","authenticated-orcid":false,"given":"Wei","family":"Shi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8548-2832","authenticated-orcid":false,"given":"Xi","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fang","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5995-7558","authenticated-orcid":false,"given":"Mingfeng","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4109-2602","authenticated-orcid":false,"given":"Jinsong","family":"Yan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yehui","family":"Tan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4041-9039","authenticated-orcid":false,"given":"Shuangnian","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guanchen","family":"Bai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weijie","family":"Cao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0152-639X","authenticated-orcid":false,"given":"Yang","family":"Cao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinhong","family":"Fei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8290-3104","authenticated-orcid":false,"given":"Jian","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4802-0292","authenticated-orcid":false,"given":"Sanbin","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peng","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0266-9715","authenticated-orcid":false,"given":"Kourong","family":"Miao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ying","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9460-9201","authenticated-orcid":false,"given":"Li","family":"Ding","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0007-7856-2651","authenticated-orcid":false,"given":"Zhiling","family":"Yan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7352-9560","authenticated-orcid":false,"given":"Liping","family":"Dou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mei","family":"Lan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shunqing","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhiguo","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3794-266X","authenticated-orcid":false,"given":"Hai","family":"Yi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hailong","family":"Yuan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaosheng","family":"Fang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hao","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2145-6643","authenticated-orcid":false,"given":"Xiaojun","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,11,25]]},"reference":[{"key":"2746_CR1","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1111\/bjh.16576","volume":"191","author":"N Gangat","year":"2020","unstructured":"Gangat N, Tefferi A. Myelofibrosis biology and contemporary management. Br J Haematol. 2020;191:152\u201370.","journal-title":"Br J Haematol"},{"key":"2746_CR2","doi-asserted-by":"publisher","DOI":"10.1016\/j.blre.2020.100691","volume":"45","author":"B Garmezy","year":"2021","unstructured":"Garmezy B, Schaefer JK, Mercer J, Talpaz MA. A provider\u2019s guide to primary myelofibrosis: pathophysiology, diagnosis, and management. Blood Rev. 2021;45:100691.","journal-title":"Blood Rev"},{"key":"2746_CR3","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1146\/annurev.med.60.041707.160528","volume":"60","author":"OI Abdel-Wahab","year":"2009","unstructured":"Abdel-Wahab OI, Levine RL. Primary myelofibrosis: update on definition, pathogenesis, and treatment. Annu Rev Med. 2009;60:233\u201345.","journal-title":"Annu Rev Med"},{"key":"2746_CR4","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1002\/ajh.26050","volume":"96","author":"A Tefferi","year":"2021","unstructured":"Tefferi A. Primary myelofibrosis: 2021 update on diagnosis, risk-stratification and management. Am J Hematol. 2021;96:145\u201362.","journal-title":"Am J Hematol"},{"key":"2746_CR5","doi-asserted-by":"publisher","first-page":"6","DOI":"10.2174\/187152912801823174","volume":"12","author":"S Ayyappan","year":"2012","unstructured":"Ayyappan S, Janakiram M, Raghupathy R. Current and emerging therapies in primary myelofibrosis. Cardiovascular Hematol Disord Drug Targets. 2012;12:6\u201320.","journal-title":"Cardiovascular Hematol Disord Drug Targets"},{"key":"2746_CR6","doi-asserted-by":"publisher","first-page":"49.e1","DOI":"10.1016\/j.jtct.2022.10.015","volume":"29","author":"M Gambella","year":"2023","unstructured":"Gambella M, Bregante S, Raiola AM, Varaldo R, Ghiso A, Schiavetti I, et al. Haploidentical hematopoietic cell transplantation for myelofibrosis in the ruxolitinib era. Transplant Cell Ther. 2023;29:49.e1\u201349.e7.","journal-title":"Transplant Cell Ther"},{"key":"2746_CR7","first-page":"873.e1","volume":"27","author":"JP Bewersdorf","year":"2021","unstructured":"Bewersdorf JP, Sheth AH, Vetsa S, Grimshaw A, Giri S, Podoltsev NA, et al. Outcomes of allogeneic hematopoietic cell transplantation in patients with myelofibrosis\u2014a systematic review and meta-analysis. Transpl Cell Ther. 2021;27:873.e1\u2013873.e13.","journal-title":"Transpl Cell Ther"},{"key":"2746_CR8","first-page":"1100.e1","volume":"30","author":"N Ghalehsari","year":"2024","unstructured":"Ghalehsari N, Castillo Tokumori F, Chen Z, Liu M, Mayer SA, Zeinah GA, et al. Transplant outcomes in myelofibrosis: impact of donor type (cord blood grafts supported by CD34+ selected cells [haplo-cord] versus matched donors). Transpl Cell Ther. 2024;30:1100.e1\u20131100.e11.","journal-title":"Transpl Cell Ther"},{"key":"2746_CR9","doi-asserted-by":"publisher","first-page":"4281","DOI":"10.1182\/bloodadvances.2024013451","volume":"8","author":"T Jain","year":"2024","unstructured":"Jain T, Estrada-Merly N, Salas MQ, Kim S, DeVos J, Chen M, et al. Donor types and outcomes of transplantation in myelofibrosis: a CIBMTR study. Blood Adv. 2024;8:4281\u201393.","journal-title":"Blood Adv"},{"key":"2746_CR10","doi-asserted-by":"publisher","first-page":"101255","DOI":"10.1016\/j.beha.2021.101255","volume":"34","author":"XJ Huang","year":"2021","unstructured":"Huang XJ. Overcoming graft failure after haploidentical transplantation: Is this a possibility? Best Pract Res Clin Haematol. 2021;34:101255.","journal-title":"Best Pract Res Clin Haematol"},{"key":"2746_CR11","doi-asserted-by":"publisher","first-page":"1223","DOI":"10.1038\/bmt.2016.98","volume":"51","author":"H Alchalby","year":"2016","unstructured":"Alchalby H, Yunus DR, Zabelina T, Ayuk F, Kr\u00f6ger N. Incidence and risk factors of poor graft function after allogeneic stem cell transplantation for myelofibrosis. Bone Marrow Transpl. 2016;51:1223\u20137.","journal-title":"Bone Marrow Transpl"},{"key":"2746_CR12","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2023.1205387","volume":"13","author":"S Jungius","year":"2023","unstructured":"Jungius S, Adam FC, Grosheintz K, Medinger M, Buser A, Passweg JR, et al. Characterization of engraftment dynamics in myelofibrosis after allogeneic hematopoietic cell transplantation including novel conditioning schemes. Front Oncol. 2023;13:1205387.","journal-title":"Front Oncol"},{"key":"2746_CR13","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1016\/j.clml.2016.02.004","volume":"16","author":"U Gergis","year":"2016","unstructured":"Gergis U, Kuriakose E, Shore T, Mayer S, Mark T, Pearse R, et al. Allogeneic transplantation for patients with advanced myelofibrosis: splenomegaly and high serum LDH are adverse risk factors for successful engraftment. Clin Lymphoma, Myeloma Leuk. 2016;16:297\u2013303.","journal-title":"Clin Lymphoma, Myeloma Leuk"},{"key":"2746_CR14","doi-asserted-by":"publisher","first-page":"2445","DOI":"10.1038\/s41375-021-01294-2","volume":"35","author":"DP McLornan","year":"2021","unstructured":"McLornan DP, Hernandez-Boluda JC, Czerw T, Cross N, Joachim Deeg H, Ditschkowski M, et al. Allogeneic haematopoietic cell transplantation for myelofibrosis: Proposed definitions and management strategies for graft failure, poor graft function and relapse: best practice recommendations of the EBMT chronic malignancies working party. Leukemia. 2021;35:2445\u201359.","journal-title":"Leukemia"},{"key":"2746_CR15","doi-asserted-by":"publisher","first-page":"1291","DOI":"10.1038\/s41409-020-01183-9","volume":"56","author":"S Giammarco","year":"2021","unstructured":"Giammarco S, Raiola AM, Di Grazia C, Bregante S, Gualandi F, Varaldo R, et al. Second haploidentical stem cell transplantation for primary graft failure. Bone Marrow Transpl. 2021;56:1291\u20136.","journal-title":"Bone Marrow Transpl"},{"key":"2746_CR16","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1016\/j.transci.2018.04.014","volume":"57","author":"ZN Ozdemir","year":"2018","unstructured":"Ozdemir ZN, Civriz Bozda\u011f S. Graft failure after allogeneic hematopoietic stem cell transplantation. Transfus Apheresis Sci. 2018;57:163\u20137.","journal-title":"Transfus Apheresis Sci"},{"key":"2746_CR17","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1002\/ajh.26020","volume":"96","author":"N Polverelli","year":"2021","unstructured":"Polverelli N, Mauff K, Kr\u00f6ger N, Robin M, Beelen D, Beauvais D, et al. Impact of spleen size and splenectomy on outcomes of allogeneic hematopoietic cell transplantation for myelofibrosis: a retrospective analysis by the chronic malignancies working party on behalf of european society for blood and marrow transplantation (EBMT). Am J Hematol. 2021;96:69\u201379.","journal-title":"Am J Hematol"},{"key":"2746_CR18","doi-asserted-by":"publisher","first-page":"755","DOI":"10.1038\/s41409-023-01968-8","volume":"58","author":"M Luther","year":"2023","unstructured":"Luther M, Henes FO, Zabelina T, Massoud R, Janson D, Wolschke C, et al. Spleen volume and length determined by computed tomography impact outcome after allogeneic stem cell transplantation for myelofibrosis. Bone Marrow Transpl. 2023;58:755\u201361.","journal-title":"Bone Marrow Transpl"},{"key":"2746_CR19","doi-asserted-by":"publisher","first-page":"796","DOI":"10.1016\/j.clml.2024.06.012","volume":"24","author":"N Gagelmann","year":"2024","unstructured":"Gagelmann N, Bose P, Gupta V, McLornan DP, Vachhani P, HK Al-Ali, et al. Consistency of spleen and symptom reduction regardless of cytopenia in patients with myelofibrosis treated with pacritinib. Clin Lymphoma, Myeloma Leuk. 2024;24:796\u2013803.","journal-title":"Clin Lymphoma, Myeloma Leuk"},{"key":"2746_CR20","doi-asserted-by":"publisher","first-page":"893","DOI":"10.1080\/10428194.2023.2179360","volume":"64","author":"M Lucijanic","year":"2023","unstructured":"Lucijanic M, Krecak I, Soric E, Galusic D, Holik H, Perisa V, et al. Palpable spleen size is differently prognostic in primary and secondary myelofibrosis. Leuk Lymphoma. 2023;64:893\u20136.","journal-title":"Leuk Lymphoma"},{"key":"2746_CR21","doi-asserted-by":"publisher","first-page":"844","DOI":"10.1002\/ajh.27252","volume":"99","author":"N Gagelmann","year":"2024","unstructured":"Gagelmann N, Hobbs GS, Campodonico E, Helbig G, Novak P, Schroeder T, et al. Splenic irradiation for myelofibrosis prior to hematopoietic cell transplantation: a global collaborative analysis. Am J Hematol. 2024;99:844\u201353.","journal-title":"Am J Hematol"},{"key":"2746_CR22","doi-asserted-by":"publisher","first-page":"588","DOI":"10.1016\/j.clml.2020.04.015","volume":"20","author":"A Malato","year":"2020","unstructured":"Malato A, Rossi E, Tiribelli M, Mendicino F, Pugliese N. Splenectomy in myelofibrosis: Indications, efficacy, and complications. Clin Lymphoma Myeloma Leuk. 2020;20:588\u201395.","journal-title":"Clin Lymphoma Myeloma Leuk"},{"key":"2746_CR23","doi-asserted-by":"publisher","first-page":"3321","DOI":"10.3324\/haematol.2023.283426","volume":"108","author":"T Jain","year":"2023","unstructured":"Jain T, Tsai HL, Elmariah H, Vachhani P, Karantanos T, Wall SA, et al. Haploidentical donor hematopoietic cell transplantation for myelodysplastic\/myeloproliferative overlap neoplasms: results from a north American collaboration. Haematologica. 2023;108:3321\u201332.","journal-title":"Haematologica"},{"key":"2746_CR24","doi-asserted-by":"publisher","DOI":"10.1177\/2040620720936935","volume":"11","author":"JH Yoon","year":"2020","unstructured":"Yoon JH, Min GJ, Park SS, Park S, Lee SE, Cho BS, et al. HLA-mismatched donor and high ferritin level showed poor clinical outcomes after allogeneic hematopoietic cell transplantation in patients with advanced myelofibrosis. Ther Adv Hematol. 2020;11:2040620720936935.","journal-title":"Ther Adv Hematol"},{"key":"2746_CR25","doi-asserted-by":"publisher","first-page":"1536","DOI":"10.1016\/j.bbmt.2019.02.019","volume":"25","author":"M Murata","year":"2019","unstructured":"Murata M, Takenaka K, Uchida N, Ozawa Y, Ohashi K, Kim SW, et al. Comparison of outcomes of allogeneic transplantation for primary myelofibrosis among hematopoietic stem cell source groups. Biol Blood Marrow Transpl: J Am Soc Blood Marrow Transpl. 2019;25:1536\u201343.","journal-title":"Biol Blood Marrow Transpl: J Am Soc Blood Marrow Transpl"},{"key":"2746_CR26","doi-asserted-by":"publisher","first-page":"222","DOI":"10.1111\/ejh.12572","volume":"96","author":"M Markiewicz","year":"2016","unstructured":"Markiewicz M, Dzierzak Mietla M, Wieczorkiewicz A, Mizia S, Helbig G, Kopera M, et al. Safety and outcome of allogeneic stem cell transplantation in myelofibrosis. Eur J Haematol. 2016;96:222\u20138.","journal-title":"Eur J Haematol"},{"key":"2746_CR27","doi-asserted-by":"publisher","first-page":"174.e1","DOI":"10.1016\/j.jtct.2024.12.021","volume":"31","author":"CL Hickey","year":"2025","unstructured":"Hickey CL, Zhang MJ, Allbee-Johnson M, Romee R, Majhail NS, Malki MMA, et al. Donor type does not impact late graft failure following reduced-intensity allogeneic hematopoietic cell transplantation with post-transplant cyclophosphamide-based graft-versus-host disease prophylaxis. Transplant Cell Ther. 2025;31:174.e1\u2013174.e12.","journal-title":"Transplant Cell Ther"},{"key":"2746_CR28","doi-asserted-by":"publisher","first-page":"698.e1","DOI":"10.1016\/j.jtct.2022.07.019","volume":"28","author":"ACM Lima","year":"2022","unstructured":"Lima ACM, Bonfim C, Getz J, do Amaral GB, Petterle RR, Loth G, et al. Untreated donor-specific HLA antibodies are associated with graft failure and poor survival after haploidentical transplantation with post-transplantation cyclophosphamide in pediatric patients with nonmalignant disorders. Transplant Cell Ther. 2022;28:698.e1\u2013698.e11.","journal-title":"Transplant Cell Ther"},{"key":"2746_CR29","doi-asserted-by":"publisher","first-page":"687.e1","DOI":"10.1016\/j.jtct.2021.04.030","volume":"27","author":"Y Xie","year":"2021","unstructured":"Xie Y, Parekh J, Tang Z, Wu D, Wu X. Donor-specific antibodies and primary graft failure in allogeneic hematopoietic stem cell transplantation: a systematic review and meta-analysis. Transplant Cell Ther. 2021;27:687.e1\u2013687.e7.","journal-title":"Transplant Cell Ther"},{"key":"2746_CR30","doi-asserted-by":"publisher","first-page":"517","DOI":"10.1111\/ejh.13689","volume":"107","author":"S Cyriac","year":"2021","unstructured":"Cyriac S, Prem S, Salas MQ, Chen S, Al-Shaibani Z, Lam W, et al. Effect of pre-transplant JAK1\/2 inhibitors and CD34 dose on transplant outcomes in myelofibrosis. Eur J Haematol. 2021;107:517\u201328.","journal-title":"Eur J Haematol"},{"key":"2746_CR31","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1159\/000508198","volume":"144","author":"L Volodin","year":"2021","unstructured":"Volodin L, Ballen KK. Allogeneic transplantation for myelofibrosis with novel graft-versus-host disease prophylaxis. Acta Haematol. 2021;144:124\u20135. https:\/\/doi.org\/10.1159\/000508198.","journal-title":"Acta Haematol"},{"key":"2746_CR32","doi-asserted-by":"publisher","first-page":"3551","DOI":"10.1038\/s41375-021-01276-4","volume":"35","author":"N Kr\u00f6ger","year":"2021","unstructured":"Kr\u00f6ger N, Sbianchi G, Sirait T, Wolschke C, Beelen D, Passweg J, et al. Impact of prior JAK-inhibitor therapy with ruxolitinib on outcome after allogeneic hematopoietic stem cell transplantation for myelofibrosis: a study of the CMWP of EBMT. Leukemia. 2021;35:3551\u201360. https:\/\/doi.org\/10.1038\/s41375-021-01276-4.","journal-title":"Leukemia"},{"key":"2746_CR33","doi-asserted-by":"publisher","unstructured":"Desai N, Rodriguez-Rodriguez S, Remberger M, Al-Shaibani E, Alfaro-Moya T, Novitzky-Basso I, et al. Effect of anti-thymocyte globulin and post-transplant cyclophosphamide on graft-versus-host disease outcomes in female donor-to-male recipient matched unrelated donor allogeneic stem cell transplantation for acute leukemia. Transpl Cell Ther. Published online July 13, 2025. https:\/\/doi.org\/10.1016\/j.jtct.2025.07.010.","DOI":"10.1016\/j.jtct.2025.07.010"},{"key":"2746_CR34","doi-asserted-by":"publisher","first-page":"991","DOI":"10.1038\/s41409-024-02276-5","volume":"59","author":"R Ma","year":"2024","unstructured":"Ma R, Zhu DP, Zhang XH, Xu LP, Wang Y, Mo XD, et al. Salvage haploidentical transplantation for graft failure after first haploidentical allogeneic stem cell transplantation: an updated experience. Bone Marrow Transpl. 2024;59:991\u20136.","journal-title":"Bone Marrow Transpl"},{"key":"2746_CR35","doi-asserted-by":"publisher","DOI":"10.3389\/fmed.2021.604085","volume":"8","author":"YQ Sun","year":"2021","unstructured":"Sun YQ, Wang Y, Wang FR, Yan CH, Cheng YF, Chen YH, et al. Graft failure in patients with hematological malignancies: a successful salvage with a second transplantation from a different haploidentical donor. Front Med. 2021;8:604085.","journal-title":"Front Med"}],"container-title":["Bone Marrow Transplantation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41409-025-02746-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41409-025-02746-4","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41409-025-02746-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,16]],"date-time":"2026-02-16T23:02:56Z","timestamp":1771282976000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41409-025-02746-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,25]]},"references-count":35,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2026,2]]}},"alternative-id":["2746"],"URL":"https:\/\/doi.org\/10.1038\/s41409-025-02746-4","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-7003361\/v1","asserted-by":"object"}]},"ISSN":["0268-3369","1476-5365"],"issn-type":[{"value":"0268-3369","type":"print"},{"value":"1476-5365","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,11,25]]},"assertion":[{"value":"29 June 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 October 2025","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 November 2025","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 November 2025","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}